Varicella Vaccine 1350PFU is a live, weakened viral vaccine used to protect children and adults against chickenpox (varicella). Each dose contains at least 1,350 Plaque-Forming Units (PFU) of the attenuated Oka strain of the virus. By introducing a gentle, harmless version of the virus to your immune system, it triggers long-lasting immunity, preventing severe skin blisters, fever, and dangerous complications.

Varicella Vaccine 1350PFU is an immunizing injection designed to build a strong, proactive defense against the highly contagious varicella-zoster virus (VZV), the root cause of chickenpox. Chickenpox spreads incredibly fast through the air via coughing or through direct touch with open fluid-filled skin blisters. Once a person is infected, the virus multiplies rapidly, leading to hundreds of itchy, painful blisters, high fevers, and extreme fatigue. While many think of it as a basic childhood illness, chickenpox can cause severe, life-threatening complications like viral pneumonia, brain swelling (encephalitis), and deep bacterial skin infections from scratching. Furthermore, the virus stays hidden in the body's nerve tissue forever, which can wake up decades later as a painful condition called shingles.

To provide reliable, long-term cellular protection before an exposure ever occurs, Varicella Vaccine 1350PFU trains the body's defense networks safely:

The active ingredient is a live but significantly weakened (attenuated) version of the varicella virus, specifically the Oka strain, measured at a minimum strength of 1,350 PFU. When a doctor or nurse injects this vaccine under the skin, the weakened virus infects local cells but is completely unable to cause the full, aggressive disease in a healthy body. Instead, it acts as a controlled training simulation for your immune system.

Specialized scout cells (antigen-presenting cells) quickly capture the weakened viral particles and present them to helper and killer T-lymphocytes. This sets off a cascade where B-lymphocytes are trained to manufacture targeted antibodies specifically shaped to neutralize the chickenpox virus. This active immune response takes a few weeks to fully mature. Once complete, the body creates long-lived memory cells. If you ever encounter the actual, wild chickenpox virus in the future, these memory cells recognize it instantly and launch a massive antibody strike that destroys the virus before it can damage your skin or internal organs.

Varicella Vaccine 1350PFU may be indicated by your pediatrician or physician for:

Routine Childhood Immunization

Protecting toddlers starting at 12 to 15 months of age, followed by a routine second dose between 4 and 6 years old.

Catch-Up Vaccination

Immunizing older children, teenagers, and adults who have never had chickenpox and were never vaccinated.

Outbreak Control

Providing post-exposure protection to healthy individuals within 3 to 5 days of being exposed to someone with chickenpox.

Varicella Vaccine 1350PFU may provide benefits such as:

• Prevents Severe Infection: Highly effective at completely preventing chickenpox, and ensures that if a breakthrough infection does occur, it is incredibly mild with few blisters.

• Eradicates Dangerous Complications: Drastically cuts down the risk of secondary bacterial skin infections, dangerous viral pneumonia, and hospitalizations.

• Protects the Whole Community: Builds "herd immunity," which indirectly protects fragile individuals who cannot get vaccines, such as newborn babies and cancer patients.

• Lowers Future Shingles Risk: Studies show children vaccinated with the weakened virus have a significantly lower chance of developing shingles later in life compared to those who catch wild chickenpox.

Common side effects of Varicella Vaccine 1350PFU may include

• Injection Site Soreness and Redness: Mild pain, a small swelling lump, or redness around the arm or thigh where the shot was given for 1 to 2 days.

• Low-Grade Fever: A mild elevation in body temperature as the immune system actively processes the vaccine simulation.

• Mild Vaccine-Related Rash: A small scattering of non-contagious, pimple-like spots near the injection site occurring up to a month after the shot.

Uncommon side effects of Varicella Vaccine 1350PFU may include

• Temporary Irritability or Restlessness

• Swollen Lymph Nodes: Small, tender lumps in the armpit or neck as local immune factories ramp up antibody production.

Serious side effects that require medical attention may include

• Severe Systemic Allergic Reaction (Anaphylaxis): Sudden swelling of the face, throat, or mouth, accompanied by severe hives, sudden wheezing, or passing out.

• High Fever Seizures (Febrile Convulsions): Short-lived body shaking caused by a sudden, rapid spike in body temperature, requiring emergency medical review.

• Severe Neurological Changes: Extreme lethargy, neck stiffness, confusion, or a loss of physical balance occurring weeks after vaccination.

• Consult your doctor if you experience any unusual, severe, or persistent symptoms while using Varicella Vaccine 1350PFU.

• Administer Varicella Vaccine 1350PFU strictly under the supervision of a licensed doctor, pharmacist, or trained immunization nurse in a clinical setting.

• Inject the medication subcutaneously (underneath the skin layer), typically into the fatty tissue of the outer upper arm or the anterolateral thigh.

• Follow the complete two-dose clinical schedule precisely, ensuring adults and teens receive their second dose at least 4 to 8 weeks after the first.

• Keep your official immunization card updated after the appointment, recording the specific date, manufacturer, and vaccine lot number.

• Remain in the clinic waiting area for at least 15 minutes after receiving the injection so healthcare staff can monitor you for immediate allergic reactions.

Varicella Vaccine 1350PFU works by initiating a controlled, subclinical infection that stimulates both the innate and adaptive arms of the human immune system. The formulation contains a minimum of 1,350 PFU of the live-attenuated Oka strain of human alphaherpesvirus 3 (Varicella-Zoster Virus). The virus has been structurally modified through sequential passages in human and animal cell cultures to eliminate its systemic pathogenicity while preserving its immunogenic surface proteins.

Upon subcutaneous administration, the weakened viral particles enter local host cells, where they replicate at a highly restricted rate.

Endogenous viral proteins are then processed and displayed on the cell surface via Major Histocompatibility Complex (MHC) class I and class II molecules.

This dual presentation activates naive CD4+ helper T-cells and CD8+ cytotoxic T-lymphocytes. The activated helper T-cells release specific cytokines that instruct B-lymphocytes to differentiate into plasma cells, which synthesize high-affinity neutralizing antibodies against VZV surface glycoproteins. This process establishes a robust baseline of circulating antibodies alongside a permanent pool of central and effector memory T and B-cells, allowing for rapid viral clearance upon future exposure to the wild-type pathogen.

• Apply a clean, cool, damp cloth over the injection spot for a few minutes if your arm feels sore or warm after the shot.

• Do not take aspirin or aspirin-containing medicines for 6 weeks after this shot to avoid a rare but serious condition called Reye's syndrome.

• Let your doctor know if you live with anyone who has a severely weakened immune system, as a precaution against very rare viral shedding.

• Avoid receiving blood transfusions, plasma, or immune globulins for at least 3 to 5 months before or 2 weeks after this shot to ensure it works correctly.

• Store the unconstituted vaccine vial continuously frozen in a specialized medical freezer at temperatures between -50°C and -15°C.

• Protect the vaccine vials completely from light by keeping them stored inside their original cardboard product box until reconstitution.

• Store the provided sterile liquid diluent vial either inside a standard refrigerator or at a stable room temperature up to 25°C.

• Inject the vaccine immediately after mixing the powder and liquid, throwing away the vial if it sits unused for more than 30 minutes.

• Standard Meals (Safe): Eating your regular breakfast or dinner has zero effect on how well your body builds antibodies to this injection.

• Gelatin Content (Caution): Individuals with severe, systemic dietary allergies to processed gelatin must inform their doctor before injection.

• Vitamin Supplements (Safe): Taking daily multivitamins or iron pills will not reduce or interfere with the vaccine's ability to create immunity.

Immune Globulins / Blood Transfusions

Severe

Antibodies found in donated blood can attack and destroy the vaccine's weakened virus before your own immune system can learn from it.

High-Dose Steroid Pills (Prednisone)

Severe

Oral steroids lower your body's defenses, which can allow the weakened vaccine virus to grow uncontrollably and cause illness.

Salicylates (Aspirin Therapy)

Severe

Taking aspirin within 6 weeks of a live varicella vaccine increases the risk of Reye's syndrome, a dangerous liver and brain condition.

• Active Severe Fevers (Caution): Delay your vaccine appointment if you are suffering from an acute infection or high fever until you fully recover.

• Untreated Active Tuberculosis (Unsafe): The vaccine should not be given to individuals with active, unmanaged tuberculosis infections.

• Severe Immunodeficiency (Unsafe): Strictly forbidden for individuals with compromised immune systems due to leukemia, HIV/AIDS, or organ transplants.

If you miss a scheduled second dose of Varicella Vaccine 1350PFU, book an appointment to receive the catch-up injection as soon as you realize the oversight. You do not need to restart the entire vaccine series from the beginning, regardless of how much time has passed since your first shot; your immune system will simply build upon the baseline protection it already established.